6 citations
,
October 2024 in “Journal of Family Medicine and Primary Care”
This systematic review details monitoring and safety guidelines for primary care physicians regarding Janus kinase and tyrosine kinase 2 inhibitors used in treating inflammatory skin conditions, emphasizing their efficacy and the importance of updated knowledge due to associated boxwarnings and increasing use.
5 citations
,
January 2021 in “Journal of The American Academy of Dermatology”
This article reflects on the history and significance of the FDA's approval of topical minoxidil for treating androgenetic alopecia in men and women, dating back to 1988 and 1991 respectively.
This study revealed significant signals of drug-related cognitive disorders in several medications that lack relevant FDA label warnings, suggesting a need for increased clinical awareness and potential label updates.
Switching from oral minoxidil back to topical due to heart issues and palpitations. Users discuss experiences with minoxidil and finasteride, with mixed results and concerns about side effects.
Minoxidil is extremely toxic to cats, and even small exposures can be fatal. Users are advised to avoid letting pets lick hair treated with topical minoxidil and to consider using oral minoxidil instead.
Minoxidil is highly toxic to pets, especially cats and dogs, even in small amounts. Many users have switched to oral minoxidil to prevent accidental exposure to their pets.
A user experienced significant hair loss after using Rogaine foam purchased from Amazon, which failed a bleach test for Minoxidil. They discovered that even legitimate Rogaine products might be faulty and advised buying from reputable sources.
Oral minoxidil is generally considered safe for hair loss at low doses, with rare side effects like pericardial effusion. Most users recommend staying at or below 2.5 mg and monitoring under medical supervision.